Back to search

Article

Phosphodiesterase type 1 regulates adenosine 2A receptor-associated cAMP signaling at the plasma membrane to increase myocardial contractility

2025-10-05

Abstract excerpt

<h4>BACKGROUND</h4> Phosphodiesterase type 1 (PDE1) inhibition exerts inodilatory effects in pre-clinical models and human heart failure patients with reduced ejection fraction (HFrEF). PDE1 hydrolyzes cyclic nucleotide cAMP in a soluble but not microsomal fraction of the human myocardium. PDE1 may exert domain-specific effects, but the mechanism whereby PDE1 compartmentalization induces an inotropic change remai...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c8013b12-60cb-5e2e-a2d8-eccc4d8304f2
DOI
10.1101/2025.10.03.680406
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Phosphodiesterase type 1 regulates adenosine 2A receptor-associated cAMP signaling at the plasma membrane to increase myocardial contractilityDOI 10.1101/2025.10.03.680406
Select a neighboring publication to make it the new centre.